In contrast, we have not detected any differences in the glycosylation level of alpha-1-antichymotrypsin or apolipoprotein B between different subtypes of LC patients as well as between LC and control subjects. This evidence concerns the gene SERPINA3 and laryngotracheoesophageal cleft.